[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Wound Closure and Advanced Wound Care Global Market – Forecast To 2026

May 2020 | 567 pages | ID: W44981BC288EN
IQ4I Research & Consultancy Pvt. Ltd.

US$ 4,950.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Wound closure and advanced wound care consists of the use of various therapeutic interventional devices to efficiently and economically close and heal a wound by integrating established wound healing concepts with the dynamic technological changes and resources. Compared to traditional wound closure and wound care products, the current wound management products assure patients and healthcare providers with improved efficacy, effectiveness and faster healing of the wounds in a non-invasive and aesthetically appealing manner. Increased utilization of the various wound management products for the numerous and varied types of wounds among the patients, elevating inclination of the value-centric global patient pool towards the technologically advanced wound management products with better therapeutic outcomes and the need to reduce hospitalization duration and ease the patient’s condition through faster wound closure and accelerated wound healing time are fuelling the wound closure and advanced wound care global market.

As estimated by IQ4I Research, the wound closure and advanced wound care global market is expected to reach $25,527.8 million by 2026 growing at a mid single digit CAGR from 2019 to 2026, due to increasing prevalence of acute and chronic wounds, escalating number of surgical procedures associated with highly prevalent lifestyle and chronic diseases, rapidly increasing geriatric population, increasing demand for highly efficient, scarless and sophisticated wound management products from the value-centric patient population, increasing R&D spending for developing innovative and technologically advanced products, growing economies and increasing demand for better healthcare facilities in emerging markets. The wound closure and advanced wound care market is segmented by wound type, product, application, end-user and geography.

Based on the wound type, the wound closure and advanced wound care global market is segmented into Acute wound and Chronic wound. Acute wound segment accounted for the largest revenue in 2019 and is expected to growing at a mid single digit CAGR from 2019 to 2026. Chronic wound segment is expected to growing at a mid single digit CAGR from 2019 to 2026.

Based on the product type, the wound closure and advanced wound care global market is segmented into Wound closure & wound care devices, Advanced wound closure & Biologics and Advanced wound dressings. Among these products, wound closure & wound care devices segment is the largest and fastest-growing product segment and is expected to grow at a mid single digit CAGR from 2019 to 2026.

Among the wound closure and wound care devices, sutures segment accounted for the largest revenue in 2019 due to their highly efficient and more accurate wound closure mechanism. Staples segment is the fastest emerging segment growing at a high single digit CAGR from 2019 to 2026 as their use is associated with strong, quick wound closure with minimal tissue reactions. In the sutures global market by operational mode, manual operated sutures or manual sutures represented the largest product segment in 2019, while automated suturing devices are expected to grow at a high single digit CAGR during the forecasted period. Among the overall sutures market by type, the absorbable sutures holds the largest share in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026.

Among the advanced wound closure and biologics, hemostats segment accounted for the largest revenue in 2019 due to their efficiency in rapid cessation of blood loss and swift wound closure. Engineered skin substitutes segment is the fastest emerging segment growing at a high single digit CAGR from 2019 to 2026 mainly due to their assurance of non-invasive wound management with better therapeutic patient outcomes. Based on the source, sealants and adhesives market has been classified as natural and synthetic sealants & adhesives. The natural sealants and adhesives segment commanded the largest revenue in 2019 and is expected to grow at a mid single digit CAGR during the forecasted period. In the natural sealants and adhesives global market by product type, fibrin sealants and adhesives segment accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026, while gelatin sealants and adhesives segment is the fastest emerging segment growing at a mid single digit CAGR from 2019 to 2026. Among the various synthetic sealants and adhesives by product type, cyanoacrylate sealants and adhesives segment accounted for the largest revenue in 2019 and is expected to grow at a low single digit CAGR from 2019 to 2026. In hemostats global market by type, mechanical hemostats segment accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026, while fibrin hemostats segment is the fastest emerging segment growing at a high single digit CAGR from 2019 to 2026.

Among the advanced wound dressings, foam dressings segment accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR during the forecasted period owing to the development of various innovative and highly comfortable foam dressings for treating the most chronic wounds.

Based on the application, the wound closure and advanced wound care global market is segmented into Burns, Ulcers, Surgical wounds, Trauma lacerations and Radionecrosis. Among these, surgical wounds segment accounted for the largest revenue in 2019 and is expected to growing at a mid single digit CAGR from 2019 to 2026. Ulcers segment is the fastest-growing segment growing at a mid single digit CAGR from 2019 to 2026 due to the elevating ulcer and chronic disease burden among the global population and the emergence of large number of technologically advanced, innovative products for ulcer management. In the ulcer global market by application type, diabetic foot ulcers segment accounted for the largest revenue in 2019 and is expected to grow at a mid single digit CAGR from 2019 to 2026.

Based on the end-user, the wound closure and advanced wound care global market is segmented into Hospitals and Ambulatory Surgery Centers (ASCs), Clinics & Community Healthcare Services and Others (Home healthcare settings and Research Institutes). Among these, Hospitals and Ambulatory Surgery Centers (ASCs) segment accounted for the largest revenue in 2019 and is expected to growing at a mid single digit CAGR from 2019 to 2026.

Based on the region, the wound closure and advanced wound care global market is segmented into North America (U.S. and Rest of North America), Europe (Germany, France, U.K and Rest of Europe), Asia-Pacific (Japan, China, India, and Rest of APAC) and Rest of the world (Brazil, Rest of Latin America and Middle East & Africa). North America accounted for the largest revenue in 2019 and is expected to growing at a mid single digit CAGR from 2019 to 2026 due to increasing adoption of advanced wound management products for the closure and accelerated healing of the highly prevalent acute and chronic wounds in the region, escalating geriatric population and increasing demand for highly efficient, scarless and sophisticated wound management products from the value-centric patient population, increasing number of researches for the development of innovative and technologically advanced products and substantial insurance coverage for wound management products.

The Asia-Pacific is the fastest-growing region in wound closure and advanced wound care market in 2019 and is expected to growing at a high single digit CAGR from 2019 to 2026 due to elevating acute and chronic wounds burden in the region, escalating number of surgical procedures associated with highly prevalent chronic diseases, increasing geriatric population, increasing demand for better healthcare facilities, increasing penetration of reimbursement schemes in developing countries, elevating demand for better healthcare facilities from the population in the region, growing economies of the region, availability of various kinds of wound management products and increasing patient awareness of these products and increasing medical tourism prospects of the region.

The wound closure and advanced wound care global market is fragmented without a dominant major player in the market that offers lots of opportunities for low barrier entry for small and medium-sized companies with distinct products in the market. Some of the major players in wound closure and advanced wound care market include Medtronic PLC (Ireland), 3M Company (U.S.), Smith & Nephew PLC (U.K.), Johnson & Johnson (J&J) (U.S.), Baxter International Inc. (U.S.), Molnlycke Holding AB (Sweden), Convatec Inc. (U.K.), Paul Hartmann AG (Germany), Integra LifeSciences Corporation (U.S.), Cardinal Health Inc. (U.S.), B. Braun Melsungen AG (Germany), Coloplast Group (Denmark) and others.

The report provides an in-depth market analysis of the above-mentioned segments across the following regions:
  • North America
    • U.S.
    • Rest of North America
  • Europe
    • Germany
    • U.K.
    • France
    • Rest of Europe
  • Asia-Pacific
    • Japan
    • China
    • Indian
    • Rest of APAC
    • Rest of the World (RoW)
    • Brazil
    • Rest of LATAM
    • Middle East and Africa
1 EXECUTIVE SUMMARY

2 INTRODUCTION

2.1 KEY TAKEAWAYS
2.2 SCOPE OF THE REPORT
2.3 REPORT DESCRIPTION
2.4 MARKETS COVERED
2.5 STAKEHOLDERS
2.6 RESEARCH METHODOLOGY
  2.6.1 MARKET SIZE ESTIMATION
  2.6.2 MARKET BREAKDOWN AND DATA TRIANGULATION
  2.6.3 SECONDARY SOURCES
  2.6.4 PRIMARY SOURCES
  2.6.5 KEY DATA POINTS FROM SECONDARY SOURCES
  2.6.6 KEY DATA POINTS FROM PRIMARY SOURCES
  2.6.7 ASSUMPTIONS

3 MARKET ANALYSIS

3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
  3.3.1 DRIVERS AND OPPORTUNITIES
    3.3.1.1 Increasing prevalence of acute and chronic wounds
    3.3.1.2 Increase in surgical procedural volume
    3.3.1.3 Elevating demand for biologics in wound care
    3.3.1.4 Emergence of technically advanced products
    3.3.1.5 Increase in aging population and prevalence of lifestyle diseases
    3.3.1.6 Acquisitions to open an array of opportunities for the market to flourish
  3.3.2 RESTRAINTS AND THREATS
    3.3.2.1 Lack of professionals in handling the sophisticated advanced wound closure and wound care techniques
    3.3.2.2 High cost of advanced wound closure and wound care devices
    3.3.2.3 Adverse effects of wound closure and wound care devices
    3.3.2.4 Unfavorable reimbursement policies in developing nations
    3.3.2.5 Stringent regulatory bodies guiding the wound closure and advanced wound care manufacturers
    3.3.2.6 Increasing preference for minimally invasive surgeries
3.4 REGULATORY AFFAIRS
  3.4.1 INTERNATIONAL ORGANIZATION FOR STANDARDIZATION
    3.4.1.1 ISO 9001: 2015 quality management system
    3.4.1.2 ISO 13485 medical devices
    3.4.1.3 ISO 10993 biological evaluation of medical devices
    3.4.1.4 ISO 14971 risk management of medical devices
    3.4.1.5 IEC 60601-1 medical electrical equipment standard
    3.4.1.6 IEC 60601-1-11 home care safety
  3.4.2 ASTM INTERNATIONAL STANDARDS
  3.4.3 U.S.
  3.4.4 CANADA
  3.4.5 EUROPE
  3.4.6 JAPAN
  3.4.7 CHINA
  3.4.8 INDIA
3.5 CLINICAL TRIALS
3.6 TECHNOLOGICAL ADVANCEMENTS
  3.6.1 NANOPARTICLE BASED WOUND HEALING
  3.6.2 SMART WOUND DRESSINGS
  3.6.3 GENE THERAPY
  3.6.4 3D BIOINK PRINTER
  3.6.5 BIOACTIVE GLASSES IN WOUND REPAIR
  3.6.6 STEM CELL TECHNOLOGY
  3.6.7 BIOCHIPS FOR WOUND HEALING
  3.6.8 MICRO ANCHOR TECHNOLOGY
3.7 PORTER’S FIVE FORCE ANALYSIS
  3.7.1 THREAT OF NEW ENTRANTS
  3.7.2 THREAT OF SUBSTITUTES
  3.7.3 BARGAINING POWER OF SUPPLIERS
  3.7.4 BARGAINING POWER OF BUYERS
  3.7.5 COMPETITIVE RIVALRY
3.8 SUPPLY CHAIN ANALYSIS
3.9 REIMBURSEMENT SCENARIO
3.10 FUNDING SCENARIO
3.11 BIOMATERIALS
3.12 SINGLE USE V/S REUSABLE DEVICES
3.13 MARKET SHARE ANALYSIS BY MAJOR PLAYERS
  3.13.1 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE ANALYSIS
  3.13.2 SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET SHARE ANALYSIS
  3.13.3 ADVANCED WOUND DRESSINGS GLOBAL MARKET SHARE ANALYSIS
  3.13.4 NEGATIVE PRESSURE WOUND THERAPY (NPWT) GLOBAL MARKET SHARE ANALYSIS
  3.13.5 ENGINEERED SKIN SUBSTITUTES AND BIOLOGICS GLOBAL MARKET SHARE ANALYSIS
3.14 WOUND CLOSURE AND ADVANCED WOUND CARE COMPANY COMPARISON TABLE BY PRODUCT TYPE, PRODUCT NAME AND APPLICATION
  3.14.1 WOUND CLOSURE DEVICES
  3.14.2 SEALANTS, ADHESIVES AND HAEMOSTATS
  3.14.3 WOUND CARE DEVICES
  3.14.4 BIOLOGICS AND ADVANCED WOUND DRESSINGS

4 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY WOUND TYPE

4.1 INTRODUCTION
4.2 ACUTE WOUND
4.3 CHRONIC WOUND

5 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY PRODUCT

5.1 INTRODUCTION
5.2 WOUND CLOSURE AND WOUND CARE DEVICES
  5.2.1 SUTURES
    5.2.1.1 Sutures by operational mode
      5.2.1.1.1 Manual sutures
      5.2.1.1.2 Automated suturing devices
    5.2.1.2 Sutures by material type
      5.2.1.2.1 Absorbable sutures
      5.2.1.2.2 Non-absorbable sutures
  5.2.2 WOUND CLOSURE STRIPS
  5.2.3 STAPLES
  5.2.4 LIGATING CLIPS
  5.2.5 NEGATIVE PRESSURE WOUND THERAPY (NPWT)
  5.2.6 HYPERBARIC OXYGEN THERAPY (HOT)
  5.2.7 ENERGY BASED DEVICES
5.3 ADVANCED WOUND CLOSURE AND BIOLOGICS
  5.3.1 SEALANTS AND ADHESIVES
    5.3.1.1 Natural sealants and adhesives
      5.3.1.1.1 Collagen sealants and adhesives
      5.3.1.1.2 Albumin sealants and adhesives
      5.3.1.1.3 Gelatin sealants and adhesives
      5.3.1.1.4 Fibrin sealants and adhesives
      5.3.1.1.5 Other natural sealants and adhesives
    5.3.1.2 Synthetic sealants and adhesives
      5.3.1.2.1 Cyanoacrylate sealants and adhesives
      5.3.1.2.2 Hydrogels sealants and adhesives
      5.3.1.2.3 Other synthetic sealants and adhesives
  5.3.2 HAEMOSTATS
    5.3.2.1 MECHANICAL HAEMOSTATS
    5.3.2.2 ACTIVE HAEMOSTATS
    5.3.2.3 FLOWABLE HAEMOSTATS
    5.3.2.4 FIBRIN HAEMOSTATS
  5.3.3 ENGINEERED SKIN SUBSTITUTES
  5.3.4 GROWTH FACTORS
5.4 ADVANCED WOUND DRESSING
  5.4.1 FOAM DRESSING
  5.4.2 HYDROCOLLOID DRESSING
  5.4.3 FILM DRESSING
  5.4.4 ANTIMICROBIAL DRESSING
  5.4.5 HYDROGEL DRESSING
  5.4.6 OTHER ADVANCED WOUND DRESSING

6 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY APPLICATION

6.1 INTRODUCTION
6.2 BURNS
6.3 ULCERS
  6.3.1 PRESSURE ULCERS
  6.3.2 VENOUS LEG ULCERS
  6.3.3 DIABETIC FOOT ULCERS
  6.3.4 ARTERIAL ULCERS
6.4 SURGICAL WOUNDS
6.5 TRAUMATIC LACERATIONS
6.6 RADIONECROSIS

7 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET, BY END-USER

7.1 INTRODUCTION
7.2 HOSPITALS AND ASC
7.3 CLINICS AND COMMUNITY HEALTHCARE SERVICES
7.4 OTHER END-USER

8 REGIONAL ANALYSIS

8.1 INTRODUCTION
8.2 NORTH AMERICA
  8.2.1 U.S.
  8.2.2 REST OF NORTH AMERICA
8.3 EUROPE
  8.3.1 GERMANY
  8.3.2 U.K.
  8.3.3 FRANCE
  8.3.4 REST OF EUROPE
8.4 APAC
  8.4.1 JAPAN
  8.4.2 CHINA
  8.4.3 INDIA
  8.4.4 REST OF APAC
8.5 ROW
  8.5.1 BRAZIL
  8.5.2 REST OF LATAM
  8.5.3 MIDDLE EAST AND AFRICA

9 COMPETITIVE LANDSCAPE

9.1 INTRODUCTION
9.2 PRODUCT LAUNCH
9.3 ACQUISITION
9.4 PRODUCT APPROVAL
9.5 PARTNERSHIPS AND EXPANSIONS
9.6 OTHERS

10 MAJOR COMPANIES

10.1 3M COMPANY
  10.1.1 OVERVIEW
  10.1.2 FINANCIALS
  10.1.3 PRODUCT PORTFOLIO
  10.1.4 KEY DEVELOPMENTS
  10.1.5 BUSINESS STRATEGY
  10.1.6 SWOT ANALYSIS
10.2 BAXTER INTERNATIONAL, INC.
  10.2.1 OVERVIEW
  10.2.2 FINANCIALS
  10.2.3 PRODUCT PORTFOLIO
  10.2.4 KEY DEVELOPMENTS
  10.2.5 BUSINESS STRATEGY
  10.2.6 SWOT ANALYSIS
10.3 B. BRAUN MELSUNGEN AG
  10.3.1 OVERVIEW
  10.3.2 FINANCIALS
  10.3.3 PRODUCT PORTFOLIO
  10.3.4 KEY DEVELOPMENTS
  10.3.5 BUSINESS STRATEGY
  10.3.6 SWOT ANALYSIS
10.4 CARDINAL HEALTH INC.
  10.4.1 OVERVIEW
  10.4.2 FINANCIALS
  10.4.3 PRODUCT PORTFOLIO
  10.4.4 KEY DEVELOPMENTS
  10.4.5 BUSINESS STRATEGY
  10.4.6 SWOT ANALYSIS
10.5 COLOPLAST GROUP
  10.5.1 OVERVIEW
  10.5.2 FINANCIALS
  10.5.3 PRODUCT PORTFOLIO
  10.5.4 KEY DEVELOPMENTS
  10.5.5 BUSINESS STRATEGY
  10.5.6 SWOT ANALYSIS
10.6 CONVATEC INC.
  10.6.1 OVERVIEW
  10.6.2 FINANCIALS
  10.6.3 PRODUCT PORTFOLIO
  10.6.4 KEY DEVELOPMENTS
  10.6.5 BUSINESS STRATEGY
  10.6.6 SWOT ANALYSIS
10.7 INTEGRA LIFESCIENCES HOLDINGS CORPORATION
  10.7.1 OVERVIEW
  10.7.2 FINANCIALS
  10.7.3 PRODUCT PORTFOLIO
  10.7.4 KEY DEVELOPMENTS
  10.7.5 BUSINESS STRATEGY
  10.7.6 SWOT ANALYSIS
10.8 JOHNSON & JOHNSON (ETHICON)
  10.8.1 OVERVIEW
  10.8.2 FINANCIALS
  10.8.3 PRODUCT PORTFOLIO
  10.8.4 KEY DEVELOPMENTS
  10.8.5 BUSINESS STRATEGY
  10.8.6 SWOT ANALYSIS
10.9 MEDTRONIC PUBLIC LIMITED COMPANY
  10.9.1 OVERVIEW
  10.9.2 FINANCIALS
  10.9.3 PRODUCT PORTFOLIO
  10.9.4 KEY DEVELOPMENTS
  10.9.5 BUSINESS STRATEGY
  10.9.6 SWOT ANALYSIS
10.10 MOLNLYCKE HOLDING AB
  10.10.1 OVERVIEW
  10.10.2 FINANCIALS
  10.10.3 PRODUCT PORTFOLIO
  10.10.4 KEY DEVELOPMENTS
  10.10.5 BUSINESS STRATEGY
  10.10.6 SWOT ANALYSIS
10.11 PAUL HARTMANN AG
  10.11.1 OVERVIEW
  10.11.2 FINANCIALS
  10.11.3 PRODUCT PORTFOLIO
  10.11.4 KEY DEVELOPMENTS
  10.11.5 BUSINESS STRATEGY
  10.11.6 SWOT ANALYSIS
10.12 SMITH & NEPHEW PLC
  10.12.1 OVERVIEW
  10.12.2 FINANCIALS
  10.12.3 PRODUCT PORTFOLIO
  10.12.4 KEY DEVELOPMENTS
  10.12.5 BUSINESS STRATEGY
  10.12.6 SWOT ANALYSIS

LIST OF TABLES

TABLE 1 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 2 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY WOUND TYPE, (2018-2026) ($MN)
TABLE 3 ACUTE WOUND GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 4 CHRONIC WOUND GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 5 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 6 WOUND CLOSURE AND WOUND CARE DEVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 7 SUTURES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 8 SUTURES GLOBAL MARKET REVENUE, BY OPERATIONAL MODE, (2018-2026) ($MN)
TABLE 9 MANUAL SUTURES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 10 AUTOMATED SUTURING DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 11 SUTURES GLOBAL MARKET REVENUE, BY MATERIAL TYPE, (2018-2026) ($MN)
TABLE 12 ABSORBABLE SUTURES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 13 NON-ABSORBABLE SUTURES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 14 WOUND CLOSURE STRIPS GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 15 STAPLES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 16 LIGATING CLIPS GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 17 NEGATIVE PRESSURE WOUND THERAPY GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 18 HYPERBARIC OXYGEN THERAPY GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 19 ENERGY BASED DEVICES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 20 ADVANCED WOUND CLOSURE AND BIOLOGICS GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 21 ADVANCED WOUND CLOSURE AND BIOLOGICS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 22 SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY SOURCE, (2018-2026) ($MN)
TABLE 23 SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 24 NATURAL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 25 NATURAL SEALANTS & ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 26 COLLAGEN SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 27 ALBUMIN SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 28 GELATIN SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 29 FIBRIN SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 30 OTHER SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 31 SYNTHETIC SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 32 SYNTHETIC SEALANTS & ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 33 CYANOACRYLATE SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 34 HYDROGEL SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 35 OTHER SEALANTS AND ADHESIVES GLOBAL MARKET REVENUE, BY REGION, (2019-2026) ($MN)
TABLE 36 HAEMOSTATS GLOBAL MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 37 HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 38 MECHANICAL HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 39 ACTIVE HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 40 FLOWABLE HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 41 FIBRIN HAEMOSTATS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 42 ENGINEERED SKIN SUBSTITUTES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 43 GROWTH FACTORS MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 44 ADVANCED WOUND DRESSING GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 45 ADVANCED WOUND DRESSING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 46 FOAM DRESSINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 47 HYDROCOLLOID DRESSINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 48 FILM DRESSINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 49 ANTIMICROBIAL DRESSINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 50 HYDROGEL DRESSINGS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 51 OTHER ADVANCED WOUND DRESSING GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 52 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 53 BURNS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 54 ULCERS GLOBAL MARKET REVENUE, BY APPLICATION TYPE, (2018-2026) ($MN)
TABLE 55 ULCERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 56 PRESSURE ULCERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 57 VENOUS LEG ULCERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 58 DIABETIC FOOT ULCERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 59 ARTERIAL ULCERS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 60 SURGICAL WOUNDS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 61 TRAUMATIC LACERATIONS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 62 RADIONECROSIS GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 63 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 64 HOSPITALS AND ASC GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 65 CLINICS AND COMMUNITY HEALTHCARE SERVICES GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 66 OTHER END-USER GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 67 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION, (2018-2026) ($MN)
TABLE 68 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, (2018-2026) ($MN)
TABLE 69 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 70 NORTH AMERICA WOUND CLOSURE AND WOUND CARE DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 71 NORTH AMERICA SUTURES MARKET REVENUE, BY OPERATIONAL MODE, (2018-2026) ($MN)
TABLE 72 NORTH AMERICA SUTURES MARKET REVENUE, BY MATERIAL TYPE, (2018-2026) ($MN)
TABLE 73 NORTH AMERICA ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 74 NORTH AMERICA SEALANTS AND ADHESIVES MARKET REVENUE, BY SOURCE TYPE, (2018-2026) ($MN)
TABLE 75 NORTH AMERICA NATURAL SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 76 NORTH AMERICA SYNTHETIC SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 77 NORTH AMERICA HAEMOSTATS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 78 NORTH AMERICA ADVANCED WOUND DRESSING MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 79 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 80 NORTH AMERICA ULCERS MARKET REVENUE, BY APPLICATION TYPE, (2018-2026) ($MN)
TABLE 81 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 82 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 83 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, (2018-2026) ($MN)
TABLE 84 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 85 EUROPE WOUND CLOSURE AND WOUND CARE DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 86 EUROPE SUTURES MARKET REVENUE, BY OPERATIONAL MODE, (2018-2026) ($MN)
TABLE 87 EUROPE SUTURES MARKET REVENUE, BY MATERIAL TYPE, (2018-2026) ($MN)
TABLE 88 EUROPE ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 89 EUROPE SEALANTS AND ADHESIVES MARKET REVENUE, BY SOURCE TYPE, (2018-2026) ($MN)
TABLE 90 EUROPE NATURAL SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 91 EUROPE SYNTHETIC SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 92 EUROPE HAEMOSTATS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 93 EUROPE ADVANCED WOUND DRESSING MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 94 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 95 EUROPE ULCERS MARKET REVENUE, BY APPLICATION TYPE, (2018-2026) ($MN)
TABLE 96 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 97 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 98 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, (2018-2026) ($MN)
TABLE 99 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 100 APAC WOUND CLOSURE AND WOUND CARE DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 101 APAC SUTURES MARKET REVENUE, BY OPERATIONAL MODE, (2018-2026) ($MN)
TABLE 102 APAC SUTURES MARKET REVENUE, BY MATERIAL TYPE, (2018-2026) ($MN)
TABLE 103 APAC ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 104 APAC SEALANTS AND ADHESIVES MARKET REVENUE, BY SOURCE TYPE, (2018-2026) ($MN)
TABLE 105 APAC NATURAL SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 106 APAC SYNTHETIC SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 107 APAC HAEMOSTATS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 108 APAC ADVANCED WOUND DRESSING MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 109 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 110 APAC ULCERS MARKET REVENUE, BY APPLICATION TYPE, (2018-2026) ($MN)
TABLE 111 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 112 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 113 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, (2018-2026) ($MN)
TABLE 114 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY PRODUCT, (2018-2026) ($MN)
TABLE 115 ROW WOUND CLOSURE AND WOUND CARE DEVICES MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 116 ROW SUTURES MARKET REVENUE, BY OPERATIONAL MODE, (2018-2026) ($MN)
TABLE 117 ROW SUTURES MARKET REVENUE, BY MATERIAL TYPE, (2018-2026) ($MN)
TABLE 118 ROW ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
TABLE 119 ROW SEALANTS AND ADHESIVES MARKET REVENUE, BY SOURCE TYPE, (2018-2026) ($MN)
TABLE 120 ROW NATURAL SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 121 ROW SYNTHETIC SEALANTS AND ADHESIVES MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 122 ROW HAEMOSTATS MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 123 ROW ADVANCED WOUND DRESSING MARKET REVENUE, BY TYPE, (2018-2026) ($MN)
TABLE 124 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY APPLICATION, (2018-2026) ($MN)
TABLE 125 ROW ULCERS MARKET REVENUE, BY APPLICATION TYPE, (2018-2026) ($MN)
TABLE 126 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY END-USER, (2018-2026) ($MN)
TABLE 127 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY COUNTRY, (2018-2026) ($MN)
TABLE 128 PRODUCT LAUNCH (2017-2019)
TABLE 129 ACQUISITION (2017-2020)
TABLE 130 PRODUCT APPROVAL (2017-2020)
TABLE 131 PARTNERSHIPS AND EXPANSIONS (2017-2020)
TABLE 132 OTHERS (2017-2020)
TABLE 133 3M: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 134 3M: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 135 3M: TOTAL REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 136 3M: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 137 BAXTER INTERNATIONAL, INC.: TOTAL SALES AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 138 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY SEGMENTS, (2017-2019) ($MN)
TABLE 139 BAXTER INTERNATIONAL, INC.: TOTAL SALES, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 140 B BRAUN MELSUNGEN: TOTAL REVENUE AND R&D EXPENSES (2016-2018) ($MN)
TABLE 141 B BRAUN MELSUNGEN: TOTAL REVENUE, BY SEGMENTS (2016-2018) ($MN)
TABLE 142 B BRAUN MELSUNGEN: TOTAL REVENUE, BY GEOGRAPHY (2016-2018) ($MN)
TABLE 143 CARDINAL HEALTH, INC.: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 144 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 145 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY MEDICAL SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 146 CARDINAL HEALTH, INC.: TOTAL REVENUE, BY SUB-SEGMENT, (2017-2019) ($MN)
TABLE 147 COLOPLAST: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 148 COLOPLAST: TOTAL REVENUE, BY SEGMENTS (2017-2019) ($MN)
TABLE 149 COLOPLAST: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 150 CONVATEC: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 151 CONVATEC: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 152 CONVATEC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 153 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 154 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE BY SEGMENTS, (2017-2019) ($MN)
TABLE 155 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE BY SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 156 INTEGRA LIFESCIENCES CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 157 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 158 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 159 JOHNSON & JOHNSON: TOTAL REVENUE, BY MEDICAL DEVICE SUB-SEGMENTS, (2017-2018) ($MN)
TABLE 160 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 161 MEDTRONIC PLC: TOTAL REVENUE AND R&D EXPENSES (2017-2019) ($MN)
TABLE 162 MEDTRONIC PLC: TOTAL REVENUE, BY SEGMENT, (2017-2019) ($MN)
TABLE 163 MEDTRONIC PLC: MINIMALLY INVASIVE THERAPIES GROUP REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 164 MEDTRONIC PLC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 165 MEDTRONIC PLC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 166 MOLNLYNCKE: TOTAL REVENUE AND R&D EXPENSES, (2016-2018) ($MN)
TABLE 167 MOLNLYCKE: TOTAL REVENUE, BY SEGMENTS, (2016-2018) ($MN)
TABLE 168 MOLNLYCKE: TOTAL REVENUE, BY GEOGRAPHY, (2016-2018) ($MN)
TABLE 169 PAUL HARTMANN AG: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 170 PAUL HARTMANN AG: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 171 PAUL HARTMANN AG: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)
TABLE 172 SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES, (2017-2019) ($MN)
TABLE 173 SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2017-2019) ($MN)
TABLE 174 SMITH & NEPHEW PLC: TOTAL REVENUE, BY ADVANED WOUND MANAGEMENT SUB-SEGMENTS, (2017-2019) ($MN)
TABLE 175 SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2017-2019) ($MN)

LIST OF FIGURES

FIGURE 1 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN)
FIGURE 2 RESEARCH METHODOLOGY: WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET
FIGURE 3 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
FIGURE 4 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET: FORECASTING MODEL
FIGURE 5 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET: MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 6 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SEGMENTATION
FIGURE 7 MARKET DYNAMICS
FIGURE 8 WOUND CLOSURE AND ADVANCED WOUND CARE: CLINICAL TRIALS (2018-2020)
FIGURE 9 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET: PORTER’S ANALYSIS
FIGURE 10 WOUND CLOSURE AND ADVANCED WOUND CARE: SUPPLY CHAIN ANALYSIS
FIGURE 11 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 12 SEALANTS, ADHESIVES AND HEMOSTATS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 13 ADVANCED WOUND DRESSINGS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 14 NPWT GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 15 ENGINEERED SKIN SUBSTITUTES AND BIOLOGICS GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2019 (%)
FIGURE 16 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY WOUND TYPE (2019 V/S 2026) (%)
FIGURE 17 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY PRODUCT (2019 V/S 2026) (%)
FIGURE 18 WOUND CLOSURE AND WOUND CARE DEVICES GLOBAL MARKET REVENUE, BY PRODUCT TYPE, (2018-2026) ($MN)
FIGURE 19 WOUND CLOSURE AND WOUND CARE DEVICES GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 20 SUTURES GLOBAL MARKET SHARE, BY OPERATIONAL MODE (2019 V/S 2026) (%)
FIGURE 21 SUTURES GLOBAL MARKET SHARE, BY MATERIAL TYPE (2019 V/S 2026) (%)
FIGURE 22 NON-ABSORBABLE SUTURES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 23 ADVANCED WOUND CLOSURE AND BIOLOGICS GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 24 SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY SOURCE (2019 V/S 2026) (%)
FIGURE 25 NATURAL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 26 SYNTHETIC SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 27 HYDROGEL SEALANTS AND ADHESIVES GLOBAL MARKET SHARE, BY REGION (2019 V/S 2026) (%)
FIGURE 28 HAEMOSTATS GLOBAL MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 29 ADVANCED WOUND DRESSING GLOBAL MARKET SHARE, BY PRODUCT TYPE (2019 V/S 2026) (%)
FIGURE 30 OTHER ADVANCED WOUND DRESSING GLOBAL MARKET SHARE, BY REGION, (2019 V/S 2026) (%)
FIGURE 31 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY APPLICATION (2019) (%)
FIGURE 32 ULCERS GLOBAL MARKET SHARE, BY APPLICATION TYPE (2019 V/S 2026) (%)
FIGURE 33 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY END-USER (2019 V/S 2026) (%)
FIGURE 34 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET REVENUE, BY REGION (2018-2026) ($MN), CAGR (%)
FIGURE 35 WOUND CLOSURE AND ADVANCED WOUND CARE GLOBAL MARKET SHARE, BY GEOGRAPHY (2019) (%)
FIGURE 36 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY WOUND TYPE, PRODUCT AND END-USER (2019 V/S 2026) (%)
FIGURE 37 NORTH AMERICA WOUND CLOSURE AND WOUND CARE DEVICE MARKET SHARE, BY PRODUCT TYPE (2019) (%)
FIGURE 38 NORTH AMERICA ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET SHARE, BY PRODUCT TYPE AND SEALANTS & ADHESIVES AND HAEMOSTATS BY TYPE (2019 V/S 2026) (%)
FIGURE 39 NORTH AMERICA NATURAL AND SYNTHETIC SEALANTS & ADHESIVES MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 40 NORTH AMERICA ADVANCED WOUND DRESSING MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 41 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY APPLICATION AND ULCERS MARKET SHARE, BY APPLICATION TYPE (2019) (%)
FIGURE 42 NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 43 U.S. WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 44 REST OF NORTH AMERICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 45 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY WOUND TYPE, PRODUCT AND END-USER (2019 V/S 2026) (%)
FIGURE 46 EUROPE WOUND CLOSURE AND WOUND CARE DEVICE MARKET SHARE, BY PRODUCT TYPE (2019) (%)
FIGURE 47 EUROPE ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET SHARE, BY PRODUCT TYPE AND SEALANTS & ADHESIVES AND HAEMOSTATS BY TYPE (2019 V/S 2026) (%)
FIGURE 48 EUROPE NATURAL AND SYNTHETIC SEALANTS & ADHESIVES MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 49 EUROPE ADVANCED WOUND DRESSING MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 50 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY APPLICATION AND ULCERS MARKET SHARE, BY APPLICATION TYPE (2019) (%)
FIGURE 51 EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 52 GERMANY WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 53 U.K. WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 54 FRANCE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 55 REST OF EUROPE WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 56 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY WOUND TYPE, PRODUCT AND END-USER (2019 V/S 2026) (%)
FIGURE 57 APAC WOUND CLOSURE AND WOUND CARE DEVICE MARKET SHARE, BY PRODUCT TYPE (2019) (%)
FIGURE 58 APAC ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET SHARE, BY PRODUCT TYPE AND SEALANTS & ADHESIVES AND HAEMOSTATS BY TYPE (2019 V/S 2026) (%)
FIGURE 59 APAC NATURAL AND SYNTHETIC SEALANTS & ADHESIVES MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 60 APAC ADVANCED WOUND DRESSING MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 61 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY APPLICATION AND ULCERS MARKET SHARE, BY APPLICATION TYPE (2019) (%)
FIGURE 62 APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 63 JAPAN WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 64 CHINA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 65 INDIA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 66 REST OF APAC WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 67 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY WOUND TYPE, PRODUCT AND END-USER (2019 V/S 2026) (%)
FIGURE 68 ROW WOUND CLOSURE AND WOUND CARE DEVICE MARKET SHARE, BY PRODUCT TYPE (2019) (%)
FIGURE 69 ROW ADVANCED WOUND CLOSURE AND BIOLOGICS MARKET SHARE, BY PRODUCT TYPE AND SEALANTS & ADHESIVES AND HAEMOSTATS BY TYPE (2019 V/S 2026) (%)
FIGURE 70 ROW NATURAL AND SYNTHETIC SEALANTS & ADHESIVES MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 71 ROW ADVANCED WOUND DRESSING MARKET SHARE, BY TYPE (2019 V/S 2026) (%)
FIGURE 72 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY APPLICATION AND ULCERS MARKET SHARE, BY APPLICATION TYPE (2019) (%)
FIGURE 73 ROW WOUND CLOSURE AND ADVANCED WOUND CARE MARKET SHARE, BY COUNTRY (2019 V/S 2026) (%)
FIGURE 74 BRAZIL WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 75 REST OF LATAM WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 76 MIDDLE EAST AND AFRICA WOUND CLOSURE AND ADVANCED WOUND CARE MARKET REVENUE, BY WOUND TYPE, PRODUCT, APPLICATION AND END-USER (2019 V/S 2026) ($MN)
FIGURE 77 KEY GROWTH STRATEGIES, (2017-2020)
FIGURE 78 SWOT: 3M COMPANY
FIGURE 79 SWOT: BAXTER INTERNATIONAL, INC.
FIGURE 80 SWOT: B. BRAUN MELSUNGEN AG
FIGURE 81 SWOT: CARDINAL HEALTH INC.
FIGURE 82 SWOT: COLOPLAST GROUP
FIGURE 83 SWOT: CONVATEC INC.
FIGURE 84 SWOT: INTEGRA LIFESCIENCES CORPORATION
FIGURE 85 SWOT: JOHNSON & JOHNSON
FIGURE 86 SWOT: MEDTRONIC PLC
FIGURE 87 SWOT: M?LNLYCKE HEALTH CARE AB
FIGURE 88 SWOT: PAUL HARTMANN AG
FIGURE 89 SWOT: SMITH & NEPHEW PLC


More Publications